Velkommen til Dansk Lungemedicinsk Selskab

Dansk Lungemedicinsk Selskab formål er at arbejde for optimal behandling, forebyggelse og forskning blandt mennesker med lungesygdomme. Dette opnås ved at sikre kvalitet i uddannelse, forskning, samarbejde og tværfaglighed.

Dansk Lungemedicinsk Selskab har repræsentanter i Danmarks Lungeforening og indgår i Dansk Selskab for Intern Medicin (DSIM) samt European Respiratory Society.

fb artDansk Lungemedicinsk Selskab har mere end 10 stående udvalg indenfor f.eks. telemedicin, retningslinjer m.m. og deltager med repræsentanter i forskellige udvalg under Sundhedsstyrelsen. Foreningen af Yngre Lungemediciner, som repræsenterer næste generation af lungemedicinske speciallæge, er organiseret under Dansk Lungemedicinsk Selskab.

Dansk Lungemedicinsk Selskab er det faglige selskab for dig, som vil skabe bedre vilkår for vore lungepatienter nu og i fremtiden.

Næste Årsmøde: 24.-25. november 2017

 

Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease

Professor: Peter Lange

Artikel link | DOI | PubMed | Journal: Am J Respir Crit Care Med I Dato: 2017 Juni 11

Kommentar til artiklen:

Medicinadhærens ved KOL er et stort problem

Denne undersøgelse belyser medicinadhærens til inhalationsmedicin hos patienter med svær KOL. I stedet for at se på, hvor meget medicin patienterne har købt på apoteket for at udregne adhærens, bruger studiet en elektronisk vurdering af inhalationsteknikken og om patienterne har taget medicin på det rigtige tidspunkt. Desværre ser det ud til at rigtig mange patienter har problemer med adhærens

Abstract

Rationale: Objective adherence to inhaled therapy by patients with chronic obstructive pulmonary disease (COPD) has not been reported.
Objectives: To objectively quantify adherence to preventer Diskus inhaler therapy by patients with COPD with an electronic audio recording device (INCA).
Methods: This was a prospective observational study. On discharge from hospital patients were given a salmeterol/fluticasone inhaler with an INCA device attached. Analysis of this audio quantified the frequency and proficiency of inhaler use.
Measurements and Main Results: Patients with COPD (n = 244) were recruited. The mean age was 71 years, mean FEV1was 1.3 L, and 59% had evidence of mild/moderate cognitive impairment. By combining time of use, interval between doses, and critical technique errors, thus incorporating both intentional and unintentional nonadherence, a measure “actual adherence” was calculated. Mean actual adherence was 22.6% of that expected if the doses were taken correctly and on time. Six percent had an actual adherence greater than 80%. Hierarchical clustering found three equally sized well-separated clusters corresponding to distinct patterns.
Cluster 1 (34%) had low inhaler use and high error rates.
Cluster 2 (25%) had high inhaler use and high error rates.
Cluster 3 (36%) had overall good adherence.

Poor lung function and comorbidities were predictive of poor technique, whereas age and cognition with poor lung function distinguished those with poor adherence and frequent errors in technique.

Conclusions: These data may inform clinicians in understanding why a prescribed inhaler is not effective and to devise strategies to promote adherence in COPD.
Keywords: COPD; inhaler; adherence; compliance; exacerbations